Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 11Neoplasms 5Stomach Neoplasms 2Small Cell Lung Carcinoma 2Ovarian Neoplasms 2Metastatic Pancreatic Adenocarcinoma 2Head and Neck Neoplasms 2Glioma 2Colorectal Neoplasms 2Biliary Tract Neoplasms 2Weight Loss 1Triple Negative Breast Neoplasms 1Solid Tumor 1Refractory Solid Tumors 1Pseudomyxoma Peritonei 1Pancreatic cancer, adult 1Pancreatic Diseases 1Oligodendroglioma 1Neoplasms, Cystic, Mucinous, and Serous 1Metastatic Adenocarcinoma of the Pancreas 1Mesothelioma 1Malignant Solid Neoplasm 1Locally Advanced Rectal Cancer (LARC) 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gliosarcoma 1Glioblastoma 1Fallopian Tube Neoplasms 1Endocrine Gland Neoplasms 1Disease 1Digestive System Neoplasms 1

Interventions

Leucovorin 3Everolimus 3temsirolimus 2Trastuzumab 2Temozolomide 2Sirolimus 2Oxaliplatin 2Octreotide 2Melphalan 2Irinotecan 2Fluorouracil 2Capecitabine 2vatalanib 1tipifarnib 1regorafenib 1pazopanib 1napabucasin 1motesanib diphosphate 1irinotecan sucrosofate 1cixutumumab 1batifiban 1Vinorelbine 1Thalidomide 1Taxes 1Streptozocin 1Sorafenib 1Paclitaxel 1Interleukin-12 Subunit p35 1Interleukin-12 1High-Energy Shock Waves 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Islet Cell × irinotecan sucrosofate × Clear all
NCT02231723 2023-11-18

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Pancreatic Cancer

Sumitomo Pharma America, Inc.

Phase 1 Completed
139 enrolled
Gastrointestinal

Pancreatic cancer, adult, Digestive System Neoplasms, Endocrine Gland Neoplasms, Adenoma, Islet Cell, Pancreatic Diseases, Pancreatic Neoplasms, Carcinoma, Islet Cell, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡